FERTIN PHARMA A/S: Financial statements 2024
CVR: 25834844
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 1,104,175,000 and a net result of DKK -259,011,000 compared with DKK -136,701,000 the year before. That is an increase of 9% compared with the year before. The profit margin was -23.5%. Equity in the 2024 report amounted to DKK 1,503,550,000. The solvency ratio was 58.5%. The company had 690 employees in the financial year.
- Revenue
- DKK 1,104,175,000
- Gross Profit
- DKK 99,947,000
- Profit/Loss
- DKK -259,011,000
- Equity
- DKK 1,503,550,000
- Total Assets
- DKK 2,570,785,000
- Employees
- 690
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 1.1B | 99.9M | -259M | 1.5B | 690 |
| 2023 | 1B | 34.1M | -136.7M | 458.4M | 654 |
| 2022 | 892.6M | 25.2M | -91.4M | 596.3M | 622 |
| 2021 | 932.5M | 161.4M | 37.6M | 681.4M | 569 |
| 2020 | 991.1M | 246.4M | 155.4M | 770.1M | 674 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
FERTIN PHARMA A/S has published its annual report for 2023. Revenue came to DKK 1,012,566,000, and the net result was DKK -136,701,000.
As of May 27, 2024, Gitte Lorenzen has joined the board of directors of FERTIN PHARMA A/S.
As of May 27, 2024, Stine Borup Hvam has joined the board of directors of FERTIN PHARMA A/S.
As of May 27, 2024, Anita Christensen Lindahl has joined the board of directors of FERTIN PHARMA A/S.
As of May 27, 2024, Bente Brændshøj has left the board of directors of FERTIN PHARMA A/S.
As of May 27, 2024, Peter Andreas Lund Dahl Jacobsen has left the board of directors of FERTIN PHARMA A/S.
As of May 26, 2024, Gitte Lorenzen has left the board of directors of FERTIN PHARMA A/S.
About FERTIN PHARMA A/S
FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.
